ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Clinical trials for ACUTE ON CHRONIC LIVER FAILURE (ACLF) explained in plain language.
Never miss a new study
Get alerted when new ACUTE ON CHRONIC LIVER FAILURE (ACLF) trials appear
Sign up with your email to follow new studies for ACUTE ON CHRONIC LIVER FAILURE (ACLF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cell injection aims to prevent deadly liver complication
Disease control ENROLLING_BY_INVITATIONThis early-phase trial tests whether injecting special liver-like cells into the abdominal muscle can help prevent or treat Small-for-Size syndrome, a serious complication that can occur after partial liver surgery. The study involves 12 patients and focuses mainly on safety, che…
Matched conditions: ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Phase: EARLY_PHASE1 • Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Exosome therapy shows promise for liver crisis in small trial
Disease control OngoingThis early-stage study tests whether exosomes (tiny particles from stem cells) can help people with sudden severe liver failure. Twenty adults will receive either standard care alone or standard care plus four doses of exosomes over 10 days. The main goal is to check safety and s…
Matched conditions: ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Phase: EARLY_PHASE1 • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC